129 related articles for article (PubMed ID: 10184452)
21. Vertical restraints among hospitals, physicians and health insurers that raise rivals' costs. A case study of Reazin v. Blue Cross and Blue Shield of Kansas, Inc. and Ocean State Physicians Health Plan, Inc. v. Blue Cross and Blue Shield of Rhode Island.
Baker JB
Am J Law Med; 1988; 14(2-3):147-69. PubMed ID: 3245541
[TBL] [Abstract][Full Text] [Related]
22. Antitrust charges fail to slow PPA action by insurer.
Burda D
Hospitals; 1986 Apr; 60(8):68-70. PubMed ID: 3754236
[No Abstract] [Full Text] [Related]
23. Vertical restraints and powerful health insurers: exclusionary conduct masquerading as managed care?
Miller FH
Law Contemp Probl; 1988; 51(2):195-236. PubMed ID: 10295963
[No Abstract] [Full Text] [Related]
24. Judge in Marshfield appeals case, clarifies views on MFNs, markets.
Healthc Syst Strategy Rep; 1995 Nov; 12(24):5-7. PubMed ID: 10154257
[No Abstract] [Full Text] [Related]
25. HMOs carry antitrust risk.
Burda D
Hospitals; 1986 Sep; 60(18):38. PubMed ID: 3744339
[No Abstract] [Full Text] [Related]
26. Competitive risks. Specialty hospitals criticized at Justice, FTC hearings for endangering community facilities.
Fong T
Mod Healthc; 2003 Mar; 33(13):6-7. PubMed ID: 12698713
[No Abstract] [Full Text] [Related]
27. Marshfield antitrust ruling ignored full market analysis.
Glassman ML
Mod Healthc; 1995 Sep; 25(36):64. PubMed ID: 10145181
[No Abstract] [Full Text] [Related]
28. Court decisions give Blues plans one win, one loss in separate antitrust cases.
Halper HR; Kazon PM
Bus Health; 1987 Mar; 4(5):51-2. PubMed ID: 10280673
[No Abstract] [Full Text] [Related]
29. On "FTC Sings the Blues" and its respondents.
Weller CD
J Health Polit Policy Law; 1982; 7(2):547-58. PubMed ID: 7108176
[No Abstract] [Full Text] [Related]
30. Too many cooks. FTC, Justice Department call consent decrees ineffective.
Taylor M
Mod Healthc; 2004 Nov; 34(44):16. PubMed ID: 15554338
[No Abstract] [Full Text] [Related]
31. Will this antitrust victory backfire on doctors?
Thomas MC
Med Econ; 1988 Aug; 65(16):62-4, 66, 68-9 passim. PubMed ID: 10288446
[No Abstract] [Full Text] [Related]
32. The 1996 Justice Department/FTC statements on physician joint ventures and multiprovider organizations.
Hoffmann ER
Med Interface; 1997 Feb; 10(2):103-6. PubMed ID: 10164786
[TBL] [Abstract][Full Text] [Related]
33. Examining exclusionary conduct of HMOs and PPOs: a case comment on Northwest Medical Laboratories v. Blue Cross and Blue Shield of Oregon.
Levitt DM
Am J Law Med; 1991; 17(3):271-88. PubMed ID: 1785621
[TBL] [Abstract][Full Text] [Related]
34. Feds pave way for AHERF deal. Proposed purchase of four remaining AHERF hospitals still faces other regulatory hurdles.
Hensley S
Mod Healthc; 1999 Jun; 29(25):26. PubMed ID: 10538593
[No Abstract] [Full Text] [Related]
35. Pueblo hospitals must look for new ways to compete, collaborate after FTC blocks deal.
Health Care Strateg Manage; 1994 Mar; 12(3):10. PubMed ID: 10132494
[No Abstract] [Full Text] [Related]
36. Physician negotiations with managed care plans: a primer of antitrust pitfalls.
Ronai SE; Hudner HK
Conn Med; 1992 Oct; 56(10):571-6. PubMed ID: 1458883
[No Abstract] [Full Text] [Related]
37. The stifling of competition by the antitrust laws: the irony of the health care industry.
Powers JA
J Law Health; 2000-2001; 15(2):223-46. PubMed ID: 12238323
[No Abstract] [Full Text] [Related]
38. FTC weighs next move in Mo. merger. Agency lost its antitrust case in court but can still pursue an administrative complaint.
Taylor M
Mod Healthc; 1999 Aug; 29(32):34. PubMed ID: 10558243
[No Abstract] [Full Text] [Related]
39. Antitrust watchdog. FTC Chairman Majoras says healthcare remains an important priority for her agency.
Taylor M
Mod Healthc; 2006 Jun; 36(26):28-30. PubMed ID: 16841649
[No Abstract] [Full Text] [Related]
40. Sign of the times? Feds scuttle Mich. Blues acquisition of HMO.
Blesch G
Mod Healthc; 2010 Mar; 40(11):18-9. PubMed ID: 20380043
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
